• Users Online: 190
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2015  |  Volume : 6  |  Issue : 1  |  Page : 33-37

Seroprevalence of HIV-1, Hepatitis B and C viruses in sickle cell disease patients in Zaria, Nigeria


1 Ahmadu Bello University Hospital, Shika-Zaria, Nigeria
2 Department of Medicine, Centre for Sickle Cell Disease, Howard University, Washington, District of Columbia; Pulmonary and Vascular Medicine Branch, National Heart, Lung and Blood Institute, NIH Bethesda, Maryland, United States of America
3 Department of Medicine, Centre for Sickle Cell Disease, Howard University, Washington, District of Columbia, United States of America
4 Cardiology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland, United States of America
5 Pulmonary and Vascular Medicine Branch, National Heart, Lung and Blood Institute, NIH Bethesda, Maryland, United States of America

Correspondence Address:
Aliyu A Babadoko
Department of Haematology and Blood Transfusion, Ahmadu Bello University Teaching Hospital, Zaria
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Get Permissions

Get Permissions

Introduction: Transfusion of blood is an important and a frequent modality of treatment for either vaso-occlussive or haemolytic crisis in patients with sickle cell disease (SCD). Sickle cell disease patients are therefore at risk of transfusion transmissible infection, blood transfusion been a recognized route of transmission of HIV, Hepatitis B and C virus particularly in resource constraint settings lacking antigen detection techniques as well as an organized and effective blood transfusion services. Aim: To determine the prevalence of HIV-1, Hepatitis B and C viral antibodies in patients with sickle cell disease. Patients and Method: A cross sectional study of 208 consecutive SCD patients at steady state and 94 healthy non-matched controls were screened for HIV-1antibodies (parallel ELIZA Determine and Uni-Gold), Hepatitis B surface antigen (NOVA) and anti-HCV (NOVA) in 2006. Results: Of the total number of 204 SCD patients screened, 102 (49%) were males and 106 (51%) were females .The mean age of the subjects was 22 ± 8 years. One hundred and nine patients (95.2%) were haemoglobin S homozygote's and 10 (4.8%) were compound heterozygote's for haemoglobin S and C. Ninety percent of the subjects reported less than 5 units of whole blood transfusion during their lifetime. Prevalence of HIV, Hepatitis B and C was 3.9%, 2.0% and 4.4% respectively. Conclusion: Prevalence of HIV, Hepatitis B and C is low in our setting and this may not be unconnected with routine screening of prospective donors. However increased public awareness, health education programs and better screening techniques will further reduce the spread of these viruses, as other routes of transmission may also play a role.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed495    
    Printed33    
    Emailed0    
    PDF Downloaded64    
    Comments [Add]    

Recommend this journal